4 резултати
FIELD OF THE DISCLOSURE
The present invention relates to novel salicylic acid derivative compound, compositions containing same and methods inhibiting STAT3 activity or for treating cancer where STAT3/5 are involved, such as in brain, breast, colon, hematologic, lung, ovarian and prostate cancers
FIELD OF THE DISCLOSURE
The present invention relates to novel salicylic acid derivative compound, compositions containing same and methods inhibiting STAT3 activity or for treating cancer where STAT3/5 are involved, such as in brain, breast, colon, hematologic, lung, ovarian and prostate cancers
FIELD OF THE DISCLOSURE
This disclosure relates to pharmaceutically active compounds obtained from natural sources. More specifically, the disclosure relates to methods of treating and preventing cancer, cardiovascular conditions, including cardiopulmonary conditions, and inflammatory responses by
TECHNICAL FIELD
This invention relates to anti-inflammatory compounds capable of releasing NO and H.sub.2S, and compositions and methods of using such compounds.
BACKGROUND OF THE INVENTION
Non-steroidal anti-inflammatory drugs (NSAIDs) are prototypical agents for treatment of inflammatory